07/17/2025
6:54 PM | BlackRock, Inc. (Filed by)
Janux Therapeutics (Subject)
| Form SCHEDULE 13G | |
06/13/2025
6:30 PM | Janux Therapeutics (Issuer)
Kung Winston (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
6:30 PM | Janux Therapeutics (Issuer)
Simson Jake (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
6:30 PM | Janux Therapeutics (Issuer)
McNulty Alana B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
6:30 PM | Hernday Natasha (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
6:30 PM | Gujrathi Sheila (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
6:30 PM | DOBMEIER ERIC (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
6:30 PM | CAPPS VICKIE L (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
6:30 PM | Barrett Ronald W (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
6:33 PM | Janux Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
7:00 PM | Doyle Janeen Noel (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for JANX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Janux Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/23/2025
7:02 PM | Doyle Janeen Noel (Reporting)
Janux Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/14/2025
11:25 AM | JANUS HENDERSON GROUP PLC (Filed by)
Janux Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/08/2025
3:30 PM | Janux Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2025
7:00 PM | Janux Therapeutics (Issuer)
Meyer Andrew Hollman (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2025
3:39 PM | Janux Therapeutics (Filer)
| Form DEF 14A | |
04/25/2025
3:40 PM | Janux Therapeutics (Filer)
| Form DEFA14A | |
04/25/2025
3:45 PM | Janux Therapeutics (Filer)
| Form ARS | |
04/23/2025
7:00 PM | Janux Therapeutics (Issuer)
Meyer Andrew Hollman (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
3:18 PM | Janux Therapeutics (Subject)
Meyer Andrew Hollman (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
3:33 PM | Janux Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
03/07/2025
5:05 PM | Janux Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
7:00 PM | Janux Therapeutics (Issuer)
Meyer Andrew Hollman (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
3:53 PM | Janux Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2025
3:55 PM | Janux Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2025
3:41 PM | Janux Therapeutics (Subject)
Paradigm Biocapital Advisors LP (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
10:24 AM | JANUS HENDERSON GROUP PLC (Filed by)
Janux Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/12/2025
8:30 AM | Adage Capital Management, L.P. (Filed by)
Janux Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/05/2025
7:00 PM | Janux Therapeutics (Issuer)
Meyer Andrew Hollman (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:00 PM | Campbell David Alan (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
3:11 PM | Campbell David Alan (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/03/2025
7:00 PM | Janux Therapeutics (Issuer)
McIver Zachariah (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/03/2025
7:01 PM | Janux Therapeutics (Issuer)
Winter Charles M. (Reporting)
| Form 3/A | |
01/03/2025
7:10 PM | Dobek Maria (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
7:10 PM | DiRaimondo Thomas (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
7:10 PM | Janux Therapeutics (Issuer)
Robinson Byron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
7:10 PM | Campbell David Alan (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
7:10 PM | Janux Therapeutics (Issuer)
Winter Charles M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
7:10 PM | Janux Therapeutics (Issuer)
McIver Zachariah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
7:00 PM | Campbell David Alan (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
9:00 AM | Campbell David Alan (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Sell this, buy that (Ad) What you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strategy: Sell This, Buy That.
In his newest presentation, Eric reveals 7 new trade ideas—pairing overhyped, vulnerable stocks with lesser-known opportunities showing real upside. These contrarian picks come from the same approach that helped him beat Wall Street legends 10-to-1 in Portfolios with Purpose. Click here to see all 7 trade ideas, including full tickers and analysis—100% free. |
12/20/2024
5:25 PM | Janux Therapeutics (Issuer)
Meyer Andrew Hollman (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:32 PM | Janux Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
3:28 PM | Janux Therapeutics (Filer)
| Form 424B5 | |
12/03/2024
7:00 PM | Campbell David Alan (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
4:10 PM | Janux Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2024
7:00 PM | Campbell David Alan (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
3:24 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Janux Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
4:58 PM | Avalon Ventures XI, L.P. (Filed by)
Janux Therapeutics (Subject)
| Form SC 13D/A | |
11/07/2024
6:08 PM | CAPPS VICKIE L (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
6:09 PM | Gujrathi Sheila (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
3:23 PM | Janux Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
3:07 PM | Janux Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
4:05 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
4:02 PM | Janux Therapeutics (Subject)
Lichter Jay (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:24 PM | Avalon BioVentures SPV I, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:30 PM | Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:17 PM | Avalon BioVentures I, LP (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:07 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/30/2024
6:30 PM | Campbell David Alan (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
3:46 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024
4:28 PM | Avalon Ventures XI, L.P. (Filed by)
Janux Therapeutics (Subject)
| Form SC 13D/A | |
10/25/2024
3:57 PM | Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024
3:44 PM | Avalon BioVentures SPV I, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024
3:51 PM | Avalon BioVentures I, LP (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024
11:37 AM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144/A | |
10/24/2024
4:53 PM | Janux Therapeutics (Subject)
Lichter Jay (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/24/2024
4:04 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/24/2024
3:15 PM | Janux Therapeutics (Issuer)
Lichter Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
4:59 PM | Avalon BioVentures SPV I, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
4:38 PM | Avalon BioVentures I, LP (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
4:39 PM | Janux Therapeutics (Subject)
Paradigm Biocapital Advisors LP (Filed by)
| Form SC 13G | |
10/23/2024
4:07 PM | Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
3:36 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024
3:20 PM | Janux Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
3:16 PM | Avalon Ventures XI, L.P. (Filed by)
Janux Therapeutics (Subject)
| Form SC 13D/A | |
10/22/2024
3:17 PM | Janux Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
10/21/2024
3:43 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024
3:25 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024
12:39 PM | Janux Therapeutics (Subject)
Lichter Jay (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
5:51 PM | Avalon BioVentures I, LP (Reporting)
Avalon BioVentures SPV I, L.P. (Reporting)
Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Issuer)
Lichter Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:57 PM | Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
3:39 PM | Avalon BioVentures SPV I, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
3:48 PM | Avalon BioVentures I, LP (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024
4:06 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024
3:24 PM | Janux Therapeutics (Subject)
Lichter Jay (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024
3:18 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024
5:14 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024
4:35 PM | Avalon BioVentures I, LP (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024
4:28 PM | Janux Therapeutics (Subject)
Lichter Jay (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024
4:25 PM | Avalon BioVentures SPV I, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Musk’s Project Colossus could mint millionaires (Ad) I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history.
And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. All the details are waiting for you now — but you need to act before the September 1st funding windo |
10/16/2024
4:17 PM | Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024
4:10 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/30/2024
7:49 PM | Avalon BioVentures I, LP (Reporting)
Avalon BioVentures SPV I, L.P. (Reporting)
Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Issuer)
Lichter Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
4:29 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/30/2024
4:34 PM | Janux Therapeutics (Subject)
Lichter Jay (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024
6:30 PM | Campbell David Alan (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
6:31 PM | DiRaimondo Thomas (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
6:32 PM | Janux Therapeutics (Issuer)
Meyer Andrew Hollman (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
5:31 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
